Advancing a Cure

Food Allergy Fact


Button - Green - Stay Informed


For Scientists

As the world’s largest private source of funding for food allergy research, FARE provides grants to qualified researchers at major medical centers worldwide. FARE-sponsored research includes clinical trials of promising therapies, as well as studies that answer crucial questions about the causes, epidemiology, and economic and social impact of food allergies.

Applying for a Grant
Thank you for your interest in applying for a FARE research grant. Please note that FARE is moving to a Request for Proposal (RFP) process for all future grants. We expect to post announcements about these programs later this fall. For more information, please check this page or call 212-207-1974.

Food Allergy Resource Initiative (FARI)
FARI is a repository of samples that are available for basic food allergy research and studies of new diagnostic tools and therapeutic strategies. Samples are available to qualified investigators at no cost. Learn more.

Current FARE-Funded Research

Clinical Trial Recruitment
FARE has partnered with ResearchMatch, a national online patient registry, to connect patients with food allergies to new clinical studies across the country. Members of FARE’s Medical Advisory Board were involved in developing a special sub-registry for patients with food allergies, which helps investigators at institutions nationwide to identify candidates for participation in food allergy clinical trials. ResearchMatch is maintained by Vanderbilt University and funded by the National Center for Research Resources, part of the NIH. Learn more about working with ResearchMatch to recruit patients for studies at approved institutions.

Food Allergy Research Alliance (FARA) 

The Food Allergy Research Alliance (FARA) is a group of leading physicians (including allergists, pediatricians, and dermatologists) dedicated to increasing patient awareness about clinical trial opportunities. FARA members are educated about research and the opportunities for patient participation at nearby clinical research facilities.